US 11,939,299 B1
4-((2-(2-(2-(4-methoxyphenyl)-4,5-diphenyl-1H-imidazol-1-yl)acetyl)hydrazono)methyl)benzoic acid as an anti-cancer compound
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Antar Ahmed Abdelhamid Ahmed, Sohag (EG); Adel A. Marzouk, Assiut (EG); Ehab S. Taher, Assiut (EG); and Amira S. Wanas, Assiut (EG)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Nov. 17, 2023, as Appl. No. 18/512,463.
Int. Cl. C07D 233/64 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC C07D 233/64 (2013.01) [A61P 35/00 (2018.01); A61P 35/02 (2018.01)] 8 Claims
 
1. A 4-((2-(2-(2-(4-Methoxyphenyl)-4,5-diphenyl-1H-imidazol-1-yl)acetyl)hydrazono)methyl)benzoic acid compound having the formula I:

OG Complex Work Unit Chemistry